To learn about Dr. Elterman and his research interests, please visit his University of Toronto profile.
Can Urol Assoc J. 2018 Jul 31;:
Pharmacotherapy versus surgery as initial therapy for patients with moderate-to-severe benign prostate hyperplasia: a cost-effectiveness analysis.
BJU Int. 2018 Aug 16;:
The novel Axonics® rechargeable sacral neuromodulation system: Procedural and technical impressions from an initial North American experience.
Neurourol Urodyn. 2018 Feb;37(S2):S1-S8
Int Neurourol J. 2017 Dec;21(4):289-294
Female Pelvic Med Reconstr Surg. 2017 Jun 27;:
Reoperation for Urinary Incontinence: A Nationwide Cohort Study, 1998-2007: Commentary on: Reoperation for Urinary Incontinence.
Urology. 2017 Apr;102:5-6
A survey of Canadian urologists' opinions and prescribing patterns of testosterone replacement therapy in men on active surveillance for low-risk prostate cancer.
Can Urol Assoc J. 2016 May-Jun;10(5-6):181-184
Int Neurourol J. 2016 Sep;20(3):270-272
Chemical vs Surgical ADT in Metastatic Prostate Cancer: A Comparison of Side Effects. Commentary on Comparison of Gonadotropin-releasing Hormone Agonists and Orchiectomy: Effects of Androgen Deprivation Therapy.
Urology. 2016 Jul;93:3-4
Can J Urol. 2016 Feb;23(1 Suppl 1):10-5
Clinician Investigator, Krembil Research Institute (Krembil)